KYMR logo

Kymera Therapeutics (KYMR) CAPEX

annual CAPEX:

$12.84M-$21.64M(-62.77%)
December 31, 2024

Summary

  • As of today (July 1, 2025), KYMR annual capital expenditures is $12.84 million, with the most recent change of -$21.64 million (-62.77%) on December 31, 2024.
  • During the last 3 years, KYMR annual CAPEX has risen by +$11.24 million (+703.88%).
  • KYMR annual CAPEX is now -62.77% below its all-time high of $34.48 million, reached on December 31, 2023.

Performance

KYMR CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

quarterly CAPEX:

$467.00K-$469.00K(-50.11%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR quarterly capital expenditures is $467.00 thousand, with the most recent change of -$469.00 thousand (-50.11%) on March 31, 2025.
  • Over the past year, KYMR quarterly CAPEX has dropped by -$6.93 million (-93.69%).
  • KYMR quarterly CAPEX is now -95.98% below its all-time high of $11.63 million, reached on December 31, 2023.

Performance

KYMR quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

TTM CAPEX:

$5.90M-$6.93M(-54.02%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR TTM capital expenditures is $5.90 million, with the most recent change of -$6.93 million (-54.02%) on March 31, 2025.
  • Over the past year, KYMR TTM CAPEX has dropped by -$31.97 million (-84.41%).
  • KYMR TTM CAPEX is now -84.41% below its all-time high of $37.87 million, reached on March 31, 2024.

Performance

KYMR TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

KYMR CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-62.8%-93.7%-84.4%
3 y3 years+703.9%-3.1%+208.3%
5 y5 years+2313.2%-66.5%+12.4%

KYMR CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-62.8%+703.9%-96.0%+347.1%-84.4%+191.7%
5 y5-year-62.8%+2313.2%-96.0%+347.1%-84.4%+269.6%
alltimeall time-62.8%+2313.2%-96.0%+347.1%-84.4%+323.1%

KYMR CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$467.00K(-50.1%)
$5.90M(-54.0%)
Dec 2024
$12.84M(-62.8%)
$936.00K(-595.2%)
$12.84M(-45.4%)
Sep 2024
-
-$189.00K(-104.0%)
$23.53M(-26.0%)
Jun 2024
-
$4.69M(-36.7%)
$31.79M(-16.1%)
Mar 2024
-
$7.40M(-36.3%)
$37.87M(+9.8%)
Dec 2023
$34.48M(+1115.8%)
$11.63M(+43.9%)
$34.48M(+48.4%)
Sep 2023
-
$8.08M(-25.0%)
$23.23M(+41.7%)
Jun 2023
-
$10.77M(+168.6%)
$16.40M(+157.7%)
Mar 2023
-
$4.01M(+974.8%)
$6.36M(+124.4%)
Dec 2022
$2.84M
$373.00K(-70.1%)
$2.84M(-4.3%)
Sep 2022
-
$1.25M(+69.5%)
$2.96M(+46.4%)
DateAnnualQuarterlyTTM
Jun 2022
-
$735.00K(+52.5%)
$2.02M(+5.7%)
Mar 2022
-
$482.00K(-3.8%)
$1.92M(+19.9%)
Dec 2021
$1.60M(-82.4%)
$501.00K(+63.7%)
$1.60M(-37.0%)
Sep 2021
-
$306.00K(-51.1%)
$2.53M(-45.4%)
Jun 2021
-
$626.00K(+281.7%)
$4.64M(-41.1%)
Mar 2021
-
$164.00K(-88.6%)
$7.87M(-13.5%)
Dec 2020
$9.10M(+1609.8%)
$1.44M(-40.3%)
$9.10M(+18.8%)
Sep 2020
-
$2.41M(-37.5%)
$7.66M(+45.9%)
Jun 2020
-
$3.85M(+176.3%)
$5.25M(+276.3%)
Mar 2020
-
$1.40M
$1.40M
Dec 2019
$532.00K
-
-

FAQ

  • What is Kymera Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Kymera Therapeutics?
  • What is Kymera Therapeutics annual CAPEX year-on-year change?
  • What is Kymera Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly CAPEX year-on-year change?
  • What is Kymera Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Kymera Therapeutics?
  • What is Kymera Therapeutics TTM CAPEX year-on-year change?

What is Kymera Therapeutics annual capital expenditures?

The current annual CAPEX of KYMR is $12.84M

What is the all time high annual CAPEX for Kymera Therapeutics?

Kymera Therapeutics all-time high annual capital expenditures is $34.48M

What is Kymera Therapeutics annual CAPEX year-on-year change?

Over the past year, KYMR annual capital expenditures has changed by -$21.64M (-62.77%)

What is Kymera Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of KYMR is $467.00K

What is the all time high quarterly CAPEX for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly capital expenditures is $11.63M

What is Kymera Therapeutics quarterly CAPEX year-on-year change?

Over the past year, KYMR quarterly capital expenditures has changed by -$6.93M (-93.69%)

What is Kymera Therapeutics TTM capital expenditures?

The current TTM CAPEX of KYMR is $5.90M

What is the all time high TTM CAPEX for Kymera Therapeutics?

Kymera Therapeutics all-time high TTM capital expenditures is $37.87M

What is Kymera Therapeutics TTM CAPEX year-on-year change?

Over the past year, KYMR TTM capital expenditures has changed by -$31.97M (-84.41%)
On this page